Clinical trial
A Single-centre, Exploratory Study to Characterise the Skin Barrier and Microbiome of Patients With Cutaneous T-cell Lymphoma (CTCL)
NCT05827107 is registered in ClinicalTrials.gov with Centre for Human Drug Research, Netherlands as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-centre, Exploratory Study to Characterise the Skin Barrier and Microbiome of Patients With Cutaneous T-cell Lymphoma (CTCL)
- Lead sponsor
- Centre for Human Drug Research, Netherlands
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 3, 2023
- Completion date
- August 31, 2023
- Enrollment
- 43 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.